MiR-185-5p measurement assists in reflecting Th1/Th2 cell imbalance, inflammatory cytokine production, and exacerbation risk for childhood asthma
Allergologia et Immunopathologia · 2023
DOI: 10.15586/aei.v51i3.810 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Allergologia et Immunopathologia, 2023. Verfasst von Chunmei Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Asthma, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
MicroRNA (miR)-185-5p participates in the pathology of asthma by regulating immune imbalance, inflammation, periostin synthesis, and smooth muscle contraction. This study intended to explore the dysregulation of miR-185p and its correlation with T-helper (Th)1, Th2 cells, and inflammatory cytokines in childhood asthma.
Methods
In 150 childhood asthma patients and 30 healthy controls (HCs), miR-185-5p from peripheral blood mononuclear cells was detected using reverse transcription-quantitative polymerase chain reaction, Th cells from peripheral blood samples were detected using flow cytometry, inflammatory cytokines from serum samples were detected using enzyme-linked immunosorbent assay.
Results
MiR-185-5p was increased in childhood asthma patients versus HCs [median (inter-quartile range (IQR)): 2.315 (1.770–3.855) versus 1.005 (0.655–1.520)] (P < 0.001). Meanwhile, miR-185-5p was negatively associated with Th1 cells (P = 0.035) but positively correlated with Th2 cells (P = 0.006) and IL-4 (P = 0.003) in childhood asthma patients; however, miR-185-5p was not linked to Th1 cells, Th2 cells, IFN-γ, or IL-4 in HCs (all P > 0.05). In addition, miR-185-5p was positively related to TNF-α (P < 0.001), IL-1β (P = 0.015), and IL-6 (P = 0.008) in childhood asthma patients, miR-185-5p was only linked to TNF-α (P = 0.040) but not IL-1β or IL-6 (both P > 0.05) in HCs. Moreover, miR-185-5p was increased in exacerbated childhood asthma patients versus remissive patients [median (IQR): 3.170 (2.070–4.905) versus 1.900 (1.525–2.615)] (P < 0.001). Besides, miR-185-5p was highest in patients with severe exacerbation followed by patients with moderate exacerbation, and lowest in patients with mild exacerbation (P = 0.010).
Conclusion
MiR-185-5p is associated with imbalanced Th1/Th2 cells, increased inflammatory cytokines along with elevated exacerbation risk, and severity in childhood asthma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Medical University, Tianjin, China.
- Department of Pediatric, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
- Department of Pediatric, Maternal and Child Health Hospital of Tangshan, Tangshan, China.
- Department of Neurosurgery, Tianjin Institute of Pediatrics, Tianjin Children's Hospital, Tianjin, China; chunyong_cai@126.com.
Zitieren
APA
Li, C., Zhao, Y., Cai, C., Liu, Z., Ma, J., Song, Y., Zhang, Y., Guo, W., Lu, Y., Xing, J., Wang, Y., Li, W., Shi, W., & Qu, H. (2023). MiR-185-5p measurement assists in reflecting Th1/Th2 cell imbalance, inflammatory cytokine production, and exacerbation risk for childhood asthma. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v51i3.810
Vancouver
Li C, Zhao Y, Cai C, Liu Z, Ma J, Song Y, et al. MiR-185-5p measurement assists in reflecting Th1/Th2 cell imbalance, inflammatory cytokine production, and exacerbation risk for childhood asthma. Allergologia et Immunopathologia. 2023. doi:10.15586/aei.v51i3.810
BibTeX
@article{Li2023,
author = {Li, Chunmei and Zhao, Yiran and Cai, Chunquan and Liu, Zhenkui and Ma, Junshuai and Song, Yanhong and Zhang, Yanwen and Guo, Weiping and Lu, Yanhui and Xing, Jing and Wang, Yanfei and Li, Wenbin and Shi, Wei and Qu, Haixin},
title = {MiR-185-5p measurement assists in reflecting Th1/Th2 cell imbalance, inflammatory cytokine production, and exacerbation risk for childhood asthma},
journal = {Allergologia et Immunopathologia},
year = {2023},
doi = {10.15586/aei.v51i3.810}
}
EUVIMED